tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

VYGR Stock Latest News

Promising Phase 1 Results and Strategic Advancements Justify Buy Rating for Voyager Therapeutics
RatingsPromising Phase 1 Results and Strategic Advancements Justify Buy Rating for Voyager Therapeutics
4h ago
VYGR
Voyager Therapeutics’ VY7523: Promising Advancements and Positive Outlook Support Buy Rating
PremiumRatings
Voyager Therapeutics’ VY7523: Promising Advancements and Positive Outlook Support Buy Rating
10h ago
VYGR
Voyager Therapeutics announces data from SAD trial of VY7523
PremiumThe Fly
Voyager Therapeutics announces data from SAD trial of VY7523
13h ago
VYGR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
17d ago
XLO
ABBV
Voyager Therapeutics price target lowered to $12 from $14 at Wells Fargo
PremiumThe Fly
Voyager Therapeutics price target lowered to $12 from $14 at Wells Fargo
20d ago
VYGR
Voyager Therapeutics: Buy Rating Affirmed Amidst Promising Alzheimer’s Program and Strong Financial Health
PremiumRatingsVoyager Therapeutics: Buy Rating Affirmed Amidst Promising Alzheimer’s Program and Strong Financial Health
20d ago
VYGR
Voyager to assess alternate payloads for SOD1 ALS gene therapy program
Premium
The Fly
Voyager to assess alternate payloads for SOD1 ALS gene therapy program
21d ago
VYGR
Voyager Therapeutics initiated with a Buy at Citi
Premium
The Fly
Voyager Therapeutics initiated with a Buy at Citi
3M ago
VYGR
Voyager upgraded, HP downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Voyager upgraded, HP downgraded: Wall Street’s top analyst calls
3M ago
HPQ
ADSK
Voyager rises after upgrade, Applied plunges after CRL: Morning Movers
PremiumThe Fly
Voyager rises after upgrade, Applied plunges after CRL: Morning Movers
3M ago
HPQ
ADSK
Wedbush upgrades Voyager to Outperform on pipeline progress
PremiumThe Fly
Wedbush upgrades Voyager to Outperform on pipeline progress
3M ago
VYGR
Voyager Therapeutics assumed with Outperform from Neutral at Wedbush
PremiumThe Fly
Voyager Therapeutics assumed with Outperform from Neutral at Wedbush
3M ago
VYGR
Voyager Therapeutics selects VY1706 for program in Alzheimer’s Disease
PremiumThe FlyVoyager Therapeutics selects VY1706 for program in Alzheimer’s Disease
3M ago
VYGR
Voyager Therapeutics Reports Strong Q3 2024 Progress
Premium
Company Announcements
Voyager Therapeutics Reports Strong Q3 2024 Progress
4M ago
VYGR
Voyager has sufficient resources for planned operating expenses into 2027
Premium
The Fly
Voyager has sufficient resources for planned operating expenses into 2027
4M ago
VYGR
Voyager Therapeutics reports Q3 EPS (16c), consensus (45c)
PremiumThe Fly
Voyager Therapeutics reports Q3 EPS (16c), consensus (45c)
4M ago
VYGR
VYGR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
VYGR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
VYGR
Voyager Therapeutics selloff on UCB news ‘excessive,’ says Leerink
PremiumThe Fly
Voyager Therapeutics selloff on UCB news ‘excessive,’ says Leerink
4M ago
VYGR
Voyager Therapeutics initiated with an Outperform at Leerink
PremiumThe Fly
Voyager Therapeutics initiated with an Outperform at Leerink
5M ago
VYGR
Voyager advances Neurocrine collaboration, selects third gene therapy candidate
PremiumThe FlyVoyager advances Neurocrine collaboration, selects third gene therapy candidate
6M ago
NBIX
VYGR
Voyager Therapeutics enters license for capsid
Premium
The Fly
Voyager Therapeutics enters license for capsid
6M ago
NVS
VYGR
Voyager Therapeutics price target lowered to $7 from $8 at Wedbush
Premium
The Fly
Voyager Therapeutics price target lowered to $7 from $8 at Wedbush
7M ago
VYGR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >